ESMO 2022 Conference Coverage
ESMO 2022 on the Results From the PREVAIL Prospective Cohort Study: Prevalence of PD-L1 High Expression in Advanced Urothelial Carcinoma
By
ESMO 2022 Conference Coverage
FEATURING
Petros Grivas
By
ESMO 2022 Conference Coverage
FEATURING
Petros Grivas
Login to view comments.
Click here to Login
GU